A multicentre, open study assessing joint disorders Under ARIMIDEX [anastrozole] (1mg/Day) as adjuvant treatment in post menopausal women with early breast cancer.
Phase of Trial: Phase IV
Latest Information Update: 05 Apr 2012
At a glance
- Drugs Anastrozole (Primary)
- Indications Early breast cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 31 Aug 2018 Biomarkers information updated
- 05 Apr 2012 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 05 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.